USPTO serial 79328850
Serial No. 79328850
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 4, 2023
- Examiner
- HARDY LUDLOW, TARAH KIM
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79328850?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Catherine Merz
Mary Catherine Merz Merz & Associates, P.C.408 Madison Street, Suite AOak Park, IL 60302UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Creating and managing data files in the nature of database management in the field of data with regard to cancer and children with a particular form of leukemia; organization of trade fairs and exhibitions for commercial purposes; organizing and conducting promotional events for others; providing consulting and information concerning the aforesaid services all in the fields of cancer research and studies and medical treatment for leukemia patients and children with a particular form of leukemia | ACTIVE | — |
| 036 | Mutual funds investment; charitable fundraising services; acquisition and collection of money, funds, subsidies and financial sponsorship, namely, financial sponsorship of cancer research and studies; financial sponsorship for cancer research and study projects and charitable works for financing cancer research and studies; financial management of monetary donations and funds; financial services, namely, wealth management services; providing consulting and information concerning the aforesaid services all in the fields of cancer research and studies and medical treatment for leukemia patients and children with a particular form of leukemia | ACTIVE | — |
| 041 | Education services, namely, providing courses and training in the field of cancer research and studies; educational services, namely, coaching and instruction in the field of medical treatment for leukemia patients and children with a particular form of leukemia; organizing and conducting congresses, conferences, workshops, seminars in the field of cancer research and studies and medical treatment for leukemia patients and children with a particular form of leukemia; providing visual and sound material for educational purposes and providing other educational materials, namely, online non-downloadable videos in the field of cancer research and studies and medical treatment for leukemia patients and children with a particular form of leukemia; publishing of books, magazines, and electronic publications; editing of books, magazines, and other electronic publications; lending of books, magazines, and electronic publications; providing consulting and information concerning the aforesaid services all in the fields of cancer research and studies and medical treatment for leukemia patients and children with a particular form of leukemia | ACTIVE | — |
| 042 | Scientific studies and research in the medical field; laboratory services for medical studies and scientific research; providing consulting and information concerning the aforesaid services all in the fields of cancer research and studies and medical treatment for leukemia patients and children with a particular form of leukemia | ACTIVE | — |
| 044 | Medical services; hospital services; medical services provided by doctors and specialist doctors; providing medical information and health information; providing consulting and information concerning the aforesaid services all in the fields of cancer research and studies and medical treatment for leukemia patients and children with a particular form of leukemia | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Stichting EuPAL Foundation
- Other trademarks owned by Stichting EuPAL Foundation
- Other trademarks owned by Stichting EuPAL Foundation
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 14, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 22, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 22, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 4, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 4, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 4, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 24, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 17, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 17, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 4, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 28, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 14, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 13, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 13, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 13, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 29, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 29, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 29, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 24, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 23, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 23, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 28, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 3, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 3, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 28, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 27, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 27, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 22, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 18, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 17, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |